Chief Editor
Art Boni, John R. Thorne Distinguished Career Professor of Entrepreneurship, Carnegie Mellon Tepper School of Business, United States
Associate Editors
Dennis Gross, CEO & Treasurer, Pennsylvania Drug Discovery Institute, United States
Moira Gunn, Host, Tech Nation on The NPR Channel on SiriusXM, and Associate Professor, University of San Francisco, United States
Editors at Large
Jim Jordan, President/CEO, Pittsburgh Life Sciences Greenhouse, Healthcare Professor, Carnegie Mellon, United States
Stephen M. Sammut, Senior Fellow, Wharton Health Care Systems and Entrepreneurial Programs, United States
Editorial Opinion Contributor
Danny Levine, Principal, Levine Media Group, United States
Editorial Advisory Board
Mark J. Ahn, Principal, Pukana Partners, Ltd., United States
Walter Bratic, Managing Director, Overmont Consulting LLC, United States
Ananda Mohan Chakrabarty, University of Illinois at Chicago, United States
Vijay Chandru, Chairman & CEO, Strand Life Sciences Pvt Ltd, India and Consulting Professor, ISL/EE, Stanford University, United States
Ben Chen, Venture Partner at Panacea Venture, United States
James Class, Director, Global Public Policy, Merck, United States
Jeremy Laurence Curnock Cook, Executive Chairman, Bioscience Managers Limited, United Kingdom
Iraj Daizadeh, Senior Manager, Amgen Inc, United States
Mitch DeKoven, Principal, Health Economics & Outcomes Research, Real-World Evidence Solutions, IMS Health, United States
Spencer G. Feldman, Partner, Olshan Frome Wolosky LLP, United States
Steve Ferguson, Deputy Director, Licensing and Entrepreneurship at NIH Office of Technology Transfer
Sharon Finch, Director, Medius Associates, United Kingdom
James Foley, Managing Director, Aqua Partners LLC, United States
Hernan Garrido-Lecca, Chairman and CEO Bioinvest; Professor of Economics and Public Policy, Universidad de San MartÃn de Porres, Lima Peru and Former Minister of Health, Peru
Thani Jambulingham, Professor and Arrupe Center Research Fellow at Saint Joseph's University, United States
Dave Jensen, Managing Director, Kincannon & Reed Global Executive Search, United States
Lynn Johnson Langer, Executive Dean, Academic Programs Foundation for Advanced Education in the Sciences, National Institutes of Health
Alan Jonason, Senior Analyst, Clearpoint Strategy Group LLC, United States
Diana Joseph, Diana Joseph Consulting, United States
Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development and Professor of Medicine, Tufts University School of Medicine, United States
John Khong, Owner, Niche Medical, J & M Technologies, Cell Sciences; Adjunct faculty, LKC Business School, Singapore management University, Singapore
Thomas J. Kowalski, Partner, Duane Morris LLP, United States
Leonard Lerer, Sudarskis & Partners, United Arab Emirates
Weijun Li, Senior Research Scientist, Global Biological Development, Bayer HealthCare Pharmaceuticals, United States
Bryan A. Liang, Professor of Anesthesiology & Director San Diego Center for Patient Safety, University of California San Diego School of Medicine; Professor of Law & Executive Director, Institute of Health Law Studies, California Western School of Law, United States
Ken Malone, Principal, Early Charm Ventures
Henry I. Miller, Senior Fellow, Pacific Research Institute, San Francisco, California, United States
Dr. Stefan Michael Miller, Partner, Kirkland & Ellis LLP, United States
Sudha Nair, Director, Global Business Development, Apotex Fermentation Inc., Canada
Robin Nott, Chair of the Laws Committee, Licensing Executives Society Britain and Ireland, United Kingdom
Mark Paris, Director, Bioinformatics & Molecular Biology Vaccinex, Inc.
Peter Pitts, President, Center for Medicine in the Public Interest
Meir Perez Pugatch, Managing Director Pugatch Consilium; Chair, Division of Health Systems Administration, School of Public Health, University of Haifa, Israel
Anthony J Russo, Chairman and CEO, Russo Partners, United States
Gene Rzucidlo, Partner at Hershkovitz & Associates
Simon Shohet, Practice Director, Pope Woodhead & Associates Ltd, United Kingdom
Grant H Skrepnek, Associate Professor, The University of Oklahoma Health Sciences Center, United States
David Smith, Of Counsel in the Health Sciences Department at Pepper Hamilton LLP, United States
Ernest Smith, Senior Vice President of Research & Chief Scientific Officer, Vaccinex, Inc., United States
Anthony Stevens, Director, Medical Options, United Kingdom
Philip Neal Sussman, Managing Partner, The Channel Group LLC, United States
Robert Wanerman, Health Care Regulatory, Reimbursement, and Compliance Attorney - Epstein Becker Green, P.C., United States
Michael Weiner, CEO, Technology Innovations, United States
Michael Vitale, Director of Commercialisation, Monash Asia-Pacific Centre for Science and Wealth Creation, Monash University, Australia
Publisher
Yali Friedman, Journal of Commercial Biotechnology